Foxp3, encoded by the human FOXP3 gene, is a transcription factor that regulates regulatory T-cell (Treg) development and function. Associations have been reported between FOXP3 gene variants and autoimmune endocrinopathy and non-endocrine autoimmune disease. The aim of this study was to investigate the possible influence of single nucleotide polymorphisms (SNP) in the FOXP3 gene on genetic predisposition to systemic lupus erythematosus (SLE). The study cohort comprised 172 SLE patients and 181 controls, who were genotyped for the FOXP3 gene variants. Of five SNPs identified, the FOXP3 −6054 ATT carrier was shown to be associated with renal disorder (odds ratio [OR] 3.26, 95% confidence interval [95% CI] 1.33–8.03, p = 0.0077). Furthermore, lower anti-dsDNA levels were found in patients with the −3279 A carrier (p = 0.0109). To the authors’ knowledge, this is the first study to investigate the association of FOXP3 SNPs with susceptibility to SLE, as well as sub-phenotype susceptibility. Although the exact role of Foxp3 and FOXP3 gene variations in SLE is still not clear, the present data support the importance of variations in the FOXP3 gene region for the etiology of certain manifestations of SLE.
FatenejadSPengSLDisorboOCraftJ. Central T cell tolerance in lupus-prone mice: influence of autoimmune background and the lpr mutation. J Immunol1998; 161: 6427–6432.
4.
HerronLREisenbergRARoperEKakkanaiahVNCohenPLKotzinBL. Selection of the T cell receptor repertoire in Lpr mice. J Immunol1993; 151: 3450–3459.
5.
RubioCFKenchJRussellDMYawgerRNemazeeD. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes. J Immunol1996; 157: 65–71.
6.
ShlomchikMJCraftJEMamulaMJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol2001; 1: 147–153.
7.
SakaguchiSSakaguchiNAsanoMItohMTodaM. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol1995; 155: 1151–1164.
8.
DankeNAKoelleDMYeeCBeheraySKwokWW. Autoreactive T cells in healthy individuals. J Immunol2004; 172: 5967–5972.
9.
AsanoMTodaMSakaguchiNSakaguchiS. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med1996; 184: 387–396.
10.
LaurieKLVan DrielIRGleesonPA. The role of CD4+CD25+ immunoregulatory T cells in the induction of autoimmune gastritis. Immunol Cell Biol2002; 80: 567–573.
11.
LiuMFWangCRFungLLWuCR. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol2004; 59: 198–202.
12.
CrispinJCMartinezAAlcocer-VarelaJ. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun2003; 21: 273–276.
13.
MiyaraMAmouraZParizotC. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol2005; 175: 8392–8400.
14.
LeeJHWangLCLinYTYangYHLinDTChiangBL. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology2006; 117: 280–286.
15.
Mellor-PitaSCitoresMJCastejonR. Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis2006; 65: 553–554.
16.
ChenYCudaCMorelL. Genetic determination of T cell help in loss of tolerance to nuclear antigens. J Immunol2005; 174: 7692–7702.
17.
SakaguchiSOnoMSetoguchiR. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev2006; 212: 8–27.
18.
HoriSNomuraTSakaguchiS. Control of regulatory T cell development by the transcription factor Foxp3. Science2003; 299: 1057–1061.
19.
FontenotJDGavinMARudenskyAY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol2003; 4: 330–336.
ParkOGrishinaILeungPSGershwinMEPrindivilleT. Analysis of the Foxp3/scurfin gene in Crohn’s disease. Ann N Y Acad Sci2005; 1051: 218–228.
22.
StephensMSmithNJDonnellyP. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet2001; 68: 978–989.
23.
StephensMDonnellyP. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet2003; 73: 1162–1169.
24.
WilliamsLMRudenskyAY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol2007; 8: 277–284.
25.
CuccaFGoyJVKawaguchiY. A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nat Genet1998; 19: 301–302.
26.
EbersGCKukayKBulmanDE. A full genome search in multiple sclerosis. Nat Genet1996; 13: 472–476.
27.
ImrieHVaidyaBPerrosP. Evidence for a Graves’ disease susceptibility locus at chromosome Xp11 in a United Kingdom population. J Clin Endocrinol Metab2001; 86: 626–630.
28.
TaylorJCGoughSCHuntPJ. A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab2006; 91: 646–653.
29.
CornelisFFaureSMartinezM. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A1998; 95: 10746–10750.
30.
BagavantHThompsonCOhnoKSetiadyYTungKS. Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease. Int Immunol2002; 14: 1397–1406.
BagavantHFuSM. Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol2009; 21: 489–494.
33.
BarretoMFerreiraRCLourencoL. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants. BMC Immunol2009; 10: 5–5.
34.
BassunyWMIharaKSasakiY. A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes. Immunogenetics2003; 55: 149–156.
35.
SanchezERuedaBOrozcoG. Analysis of a GT microsatellite in the promoter of the foxp3/scurfin gene in autoimmune diseases. Hum Immunol2005; 66: 869–873.
